News Releases

Anixa Biosciences Announces Completion of Pre-Sub Meeting with FDA for its Cchek™ Cancer Diagnostic Test

December 19, 2018

Anixa Biosciences Presents Positive Data on its Liquid Biopsy for Early Detection of Breast Cancer at AACR Conference

December 3, 2018

Anixa Biosciences To Present Cchek™ Breast Cancer Data at AACR Special Conference on Tumor Immunology and Immunotherapy

November 15, 2018

Anixa Biosciences Presents Positive Data from its Artificial Intelligence Powered Liquid Biopsy for Prostate Cancer at SITC Conference

November 12, 2018

Anixa Biosciences to Present at SITC Annual Meeting

October 29, 2018

Anixa Biosciences Announces Scheduling of Pre-Sub Meeting with FDA for its Cchek™ Cancer Diagnostic Test

October 24, 2018

Moffitt Cancer Center and Anixa Biosciences Announce Completion of Pre-IND Meeting with FDA for CAR-T Therapy

October 22, 2018

Anixa Biosciences Releases Data Presented at AACR Artificial Intelligence Conference

October 17, 2018

Anixa Biosciences Files Pre-Submission and Requests Meeting with FDA Regarding Cchek™ Artificial Intelligence based Cancer Detection Technology

October 15, 2018

Anixa Biosciences Appoints Leading Researchers in Immuno-Oncology to its Scientific Advisory Board

October 11, 2018

1
2
3
4
Next »

Latest News & Events

Jul 29, 2019

Anixa Biosciences Announces VA North Texas Health Care System to Join Cchek™ Prostate Cancer Study

Read More...

Jul 24, 2019

Anixa Biosciences Announces Additional Patent Issued on Cancer Detection Technology

Read More...

Jul 22, 2019

Anixa Biosciences Announces U.S. Department of Veterans Affairs VA Maryland Health Care System Joins Cchek™ Prostate Cancer Study

Read More...

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.